increased the lymph node homing by 144% in athymic nude mice. This is the first report on exploiting trogocytosis to rapidly and transiently modify lymphocytes, without direct genetic intervention, for adoptive transfer.
Introduction
Natural killer (NK) cells are part of the innate arm of immune system owing to their hallmark "readiness" to combat viral infections and involvement in tumor immune surveillance without prior antigen priming. However, recent insights into NK cell function have led to the understanding that these cells participate in innate as well as adaptive immune responses. 1 This increases the attractiveness of NK cells as effectors in adoptive immunotherapy for cancer.
Until recently, the major limiting factor to the clinical application and efficacy of NK cells was the difficulty in obtaining sufficient cell numbers for adoptive transfer.
Development of novel methods of expanding primary human NK cells ex vivo has
renewed interest in NK cells for immunotherapy for cancer. [2] [3] [4] [5] [6] Expanded NK cells have enhanced expression of activating receptors, 4,7,8 that in turn improves their antitumor cytotoxicity. Where activating receptors did not sufficiently elicit an antitumor response, researchers augmented the antitumor effect of NK cells by expression of chimeric antigen receptors. [9] [10] [11] Ultimately, the success of NK cell adoptive immunotherapy for cancer depends not only on target recognition but also on homing of NK cells to the tumor target in vivo. Thus, the effector cells must express the appropriate chemokine receptors.
Cancer cells express a wide array of chemokines and chemokine receptors that are instrumental in tumor survival 12 and metastatic spread. 13 Lymph nodes, particularly the tumor-draining nodes, are the foci of metastatic spread of tumors for a vast number of cancer types. 13, 14 The expression of CCR7, a member of the G protein-coupled In this study, we sought to express CCR7 on expanded NK cells ex vivo to facilitate lymph node homing upon adoptive transfer. Although investigators have used viral vectors to gene modify NK cell lines 10, 24 and primary NK cells, 9 ,25 owing to safety concerns over integrating viral vectors there has been a recent shift in emphasis towards non-viral methods of gene transfer, particularly non-integrating, mRNA based electroporation approaches. 11 However, electroporation of NK cells has been difficult in that the transfection efficiency and viability of NK cells are low and high-throughput Uptake of membrane molecules by NK cells from their targets was first described for the transfer of human leukocyte antigen-C, 27 by a process later termed as trogocytosis.
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Trogocytosis is a fast, contact dependent uptake of membrane fragment and molecules contained therein, from "donor" cell by the "acceptor" cell, and is distinct from other mechanisms of intercellular exchanges such as nanotubes and exosomes. Although the process of trogocytosis has been well studied both in vitro and in vivo using various cell types, to date there have been no reports demonstrating that trogocytosis can be exploited as a tool for engineering expression of cell membrane molecules on immune cells for therapeutic applications. We proposed the use of trogocytosis to engineer CCR7 expression on expanded human NK cells for adoptive immunotherapy applications. In the present study we showed that CCR7 acquired by NK cells via trogocytosis enhances the lymph node homing of these cells upon adoptive transfer to athymic nude mice. To the best of our knowledge, this is the first report to suggest and validate trogocytosis as a tool for modifying lymphocytes with chemokine receptors in place of gene transfer for the purposes of adoptive immunotherapy.
Methods

Cells and cell lines
The K562-based artificial antigen-presenting cell line CJLCKT64.86.41BBL.CD19.MBIL21 (Clone9.mbIL21) was described previously for expansion of NK cells ex vivo.
7,8 CCR7 cDNA (CCR7/pCMV-XL4) was obtained from
Origene, and the coding sequence was amplified (primers listed in Table 1 
Modifying NK cells by trogocytosis
Expanded NK cells were thawed and allowed to rest overnight in NK cell culture media.
Trogocytosis of CCR7 was induced by co-culturing NK cells with γ-irradiated (100 Gy) Clone9.CCR7 cells, at an acceptor:donor cell ratio of 1:1 in a 24-well plate. The plate was spun for 2 minutes at 100g to initiate cell contact and incubated at 37°C in 5% CO 2 .
NK cells co-cultured with Clone9.mbIL21 cells served as control. The cells from the cocultures were recovered for analysis at the times indicated and pipetted to dissociate cell synapses, fixed for 15 minutes at room temperature using a 1% formaldehyde solution in phosphate-buffered saline, and stained for CD16 PE-Cy5, CD56 PE-Cy5, and CCR7 FITC. The percentage of the NK cells that acquired CCR7 was determined using flow cytometry. Uptake of multiple surface receptors from Clone9.CCR7 cells by NK cells was also assessed using flow cytometry. NK cells with (co-cultured with Clone9.CCR7 cells) and without (co-cultured with Clone9.mbIL21 cells) acquired CCR7 are henceforth referred to as CCR7 + NK and CCR7 -NK cells, respectively.
To evaluate the kinetics of persistence of acquired CCR7, NK cells from three healthy individuals were co-cultured for 1 hour as described above with donor cells that were subjected to freezing and thawing. Donor cells (5 x 10 6 cells/mL of culture medium) were frozen in a dry-ice/ethanol bath for 2 minutes and then thawed in a 37°C
water bath. Optimal amount of freezing and thawing was determined where more than 95% of the cells stained positive for trypan blue without significant disruption of the The NK cells were returned to culture in NK cells medium as described above, and CCR7 expression on the cells was assessed over time.
RT-PCR analysis
Transcription of CCR7 mRNA in donor as well as NK cells was assessed using reverse transcriptase (RT)-polymerase chain reaction (PCR). Briefly, total RNA was isolated from untreated NK cells, K562 donor cell lines (Clone9.mbIL21, Clone9.CCR7),
CCR7
+ NK, and CCR7 -NK cells and T cells (positive control), and cDNA was then synthesized using oligo(dT) primers with SuperScript III first-strand synthesis supermix (Invitrogen). To detect CCR7 transgene expression in donor cells, RT-PCR was performed with primers that bind within the coding region of the transcript. To detect the endogenous CCR7 transcripts in the acceptor NK cells, a different primer set was used with the reverse primer designed to bind in the 3'-untranslated region of the mRNA, which was lacking in the CCR7 transgene. The PCR products were run on a 1.2% agarose gel. The primers used in this analysis are listed in Table 1 .
Fluorescence microscopy
NK cells were co-cultured with Clone9.CCR7 cells for 15 minutes at 37°C, gently recovered to prevent disturbing the cell aggregates, centrifuged at 80g for 5 minutes,
For personal use only. on June 5, 2017. by guest www.bloodjournal.org From and fixed in a 1% formaldehyde solution. The cells were then stained with anti-CCR7 FITC, anti-CD16 PE, and anti-CD56 PE antibodies. Next, the cells were transferred onto glass slides using a cytospin (Cytopro 7620 cytocentrifuge; Wescor) and imaged using a Nikon Eclipse TE2000-U fluorescence microscope.
Transwell migration assay
NK cells were co-cultured with freeze/thaw treated Clone9.mbIL21 or Clone9.CCR7 Committee.
Statistical analysis
Statistical analyses were performed using the GraphPad Prism software using nonparametric, Wilcoxon test. Correlation analysis was done using non-linear curve fit 12 method and significance of correlation assessed by Pearson test. P values less than 0.05 were considered statistically significant.
Results
Expanded human NK cells acquire CCR7 from K562-based donor cells via trogocytosis
We genetically modified the Clone9.mbIL21 cell line to express CCR7 using Sleeping Beauty transposon/transposase vectors (Supplemental Figure 1A ) and generated the Clone9.CCR7 cell line by sorting for CCR7-positive cells 2 weeks after electroporation.
After 1 month of culture, we confirmed that the Clone9.CCR7 cell line had stable expression of CCR7 (Supplemental Figure 1B) .
We generated the NK cells used in the study by expanding buffy coat-derived PBMCs on Clone9.mbIL21 cells as we described previously. For personal use only. on June 5, 2017. by guest www.bloodjournal.org From 
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We further evaluated the kinetics of CCR7 uptake by NK cells from irradiated Clone9.mbIL21 or Clone9.CCR7 cells as a potential clinically applicable approach, and again observed uptake of CCR7 by NK cells. By 1 hour of co-culture, a median of 80% of NK cells were positive for CCR7 ( Figure 1C ). The uptake peaked by 3 hours, followed by a marginal decrease and stabilization at a median of 76% of NK cells up to 8 hours.
There was no expression of CCR7 on NK cells co-cultured with Clone9.mbIL21 during this period. These data suggested that 1-3 hours of NK-cell co-culture with Clone9.CCR7 was optimal for achieving maximal uptake of CCR7 by expanded NK cells in our system. In subsequent experiments, we used 1 hour as the standard coincubation period.
To exclude induction of gene expression, we assessed for onset of endogenous To investigate if trogocytosis was the mechanism of CCR7 uptake by NK cells, we imaged NK cells 15 minutes after co-culture with Clone9.CCR7 cells using fluorescence microscopy. We observed three stages of CCR7 acquisition by NK cells. Figure 2B ).
These data confirmed that CCR7 is indeed acquired from donor cells via trogocytosis.
Persistence of acquired CCR7 expression on NK cells
To determine the kinetics of loss of acquired CCR7 receptors from NK cells, we co- panels ii and iii). We observed that NK cells were able to extract CCR7 from Clone9.CCR7 cells subjected to a single freezing/thawing cycle although at a lower level than from live Clone9.CCR7 cells (Supplemental Figure 2B) . Donor cells treated with further freeze thaw cycles did not support uptake of CCR7 by trogocytosis (data not shown). To understand the reason for diminished trogocytosis we assessed if trogocytosis was dependent on NK cell lysis of the targets. We stained NK cells for CCR7 and CD107a, a marker for degranulation, after co-culture with live and freeze/thawed donor Clone9.CCR7 cells (Supplemental Figure 2C) .
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of NK cells co-cultured with live donor cells were dual positive for CCR7 and CD107a
(1:1 ratio). Following freeze/thaw treatment there was a decrease in overall trogocytosis and degranulation by NK cells and increase in CCR7 -
CD107a
-cell population (Supplemental Figure 2D) . However, we noted that the percentage of CCR7 + NK cells remained higher than CD107a + NK cells and the ratio shifted to 1:0.58 with a median of 31% NK cells that are CCR7 + CD107a
-. This data suggests that trogocytosis in this system is not absolutely dependent on donor cell lysis, in agreement with previous findings. 26 The data however shows that membrane integrity of target cells may play an important role in NK cell engagement, resulting in both degranulation and trogocytosis.
To assess the kinetics of loss of acquired receptors, we separated NK cells from 
Acquired CCR7 expression confers migratory properties to NK cells in vitro
We assessed the functional integration of acquired CCR7 in NK cells by studying their migration potential towards chemokine ligands CCL19 and CCL21 using transwell migration assay. We separated NK cells co-cultured with freeze/thaw treated Clone9.mbIL21 or Clone9.CCR7 cells on Ficoll-Paque and assessed them for CCR7 
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CD16 and CD56 remained unaltered during the co-culture period ( Figure 6D ). We assessed the kinetics of loss of acquired wild type receptors CD64, CD86 and CD137L.
The decline in NK cells positive for acquired receptors to a median of 50% (t ½ ), relative to time 0 hours, was most rapid for CD64 (~ 4 hours), intermediate for CD137L (~ 8 hours) and slowest for CD86 (~ 24 hours) ( Figure 6E ). This data shows that receptors acquired through trogocytosis may decay at varying rates.
Discussion
In this study, we proposed utilizing trogocytosis to modify NK cells in place of gene transfer and demonstrated the feasibility of this approach in conferring to NK cells CCR7-mediated ability to migrate to lymph nodes following adoptive transfer. We also demonstrated the robustness of trogocytosis by simultaneously transferring multiple receptors to NK cells.
Owing to the importance of chemokines and chemokine receptors in cancer progression and lymphocyte migration to tumors, we seek to improve homing of adoptively transferred NK cells to tumors or sites of tumor metastasis in vivo. In the present study, we used CCR7 as a generic chemokine receptor model that is relevant to many tumor types that metastasize to lymph nodes driven by their expression of CCR7 or CXCR4. 14, 45 We propose that expression of CCR7 on adoptively transferred NK cells Based on our data in this study, we propose trogocytosis as a tool to transiently modify expanded human NK cells with chemokine receptors and other membrane bound molecules without using gene transfer for adoptive immunotherapy for cancer.
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